TrialBMC cancer2009

Treatment of advanced, recurrent, resistant to previous treatments basal and squamous cell skin carcinomas with a synergistic formulation of interferons. Open, prospective study.

Lorenzo Anasagasti-Angulo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.